Boston Partners boosted its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 20.1% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,188,021 shares of the company's stock after purchasing an additional 1,034,674 shares during the quarter. Boston Partners owned about 1.37% of GE HealthCare Technologies worth $404,501,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the business. NBH Bank bought a new position in GE HealthCare Technologies in the 2nd quarter worth approximately $26,000. First Eagle Investment Management LLC boosted its position in shares of GE HealthCare Technologies by 77.6% in the third quarter. First Eagle Investment Management LLC now owns 437 shares of the company's stock valued at $29,000 after acquiring an additional 191 shares during the period. Provenance Wealth Advisors LLC boosted its position in shares of GE HealthCare Technologies by 401.0% in the third quarter. Provenance Wealth Advisors LLC now owns 491 shares of the company's stock valued at $32,000 after acquiring an additional 393 shares during the period. Fortitude Family Office LLC boosted its position in shares of GE HealthCare Technologies by 249.1% in the third quarter. Fortitude Family Office LLC now owns 597 shares of the company's stock valued at $39,000 after acquiring an additional 426 shares during the period. Finally, Heritage Family Offices LLP acquired a new stake in shares of GE HealthCare Technologies in the third quarter worth $44,000. Institutional investors and hedge funds own 82.06% of the company's stock.
Analyst Ratings Changes
GEHC has been the topic of a number of research reports. Oppenheimer reaffirmed an "outperform" rating on shares of GE HealthCare Technologies in a research report on Thursday, July 30th. Evercore reissued an "outperform" rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a report on Thursday, July 30th. Citigroup increased their price target on shares of GE HealthCare Technologies from $71.00 to $79.00 and gave the company a "neutral" rating in a report on Thursday, October 29th. Zacks Research upgraded shares of GE HealthCare Technologies from a "strong sell" rating to a "hold" rating in a research report on Tuesday, August 11th. Finally, Wolfe Research began coverage on shares of GE HealthCare Technologies in a report on Tuesday, October 20th. They set a "peer perform" rating on the stock. Twelve research analysts have rated the stock with a Buy rating and eleven have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $82.52.
Read Our Latest Stock Report on GEHC
GE HealthCare Technologies Price Performance
Shares of NASDAQ:GEHC opened at $83.66 on Thursday. GE HealthCare Technologies Inc. has a 1-year low of $58.75 and a 1-year high of $89.77. The firm has a market capitalization of $37.83 billion, a PE ratio of 17.65, a PEG ratio of 2.06 and a beta of 0.65. The business's 50 day moving average is $71.50 and its 200-day moving average is $70.17. The company has a current ratio of 1.30, a quick ratio of 1.01 and a debt-to-equity ratio of 0.86.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, October 28th. The company reported $1.34 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.20 by $0.14. The business had revenue of $5.51 billion for the quarter, compared to analysts' expectations of $5.35 billion. GE HealthCare Technologies had a return on equity of 20.45% and a net margin of 9.96%. GE HealthCare Technologies's quarterly revenue was up 7.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.07 earnings per share. Sell-side analysts predict that GE HealthCare Technologies Inc. will post 5.02 earnings per share for the current year.
GE HealthCare Technologies Increases Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, November 13th. Shareholders of record on Friday, October 23rd were paid a dividend of $0.04 per share. This is an increase from GE HealthCare Technologies's previous quarterly dividend of $0.0350. This represents a $0.16 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date was Friday, October 23rd. GE HealthCare Technologies's dividend payout ratio is presently 3.38%.
GE HealthCare Technologies Profile
(
Free Report)
GE HealthCare Technologies Inc. is a global medical technology company that develops and provides equipment, software and services for healthcare providers. Its offerings support medical imaging, diagnosis, patient monitoring and treatment across a range of clinical settings. The company's products include magnetic resonance imaging, computed tomography, molecular imaging and ultrasound systems, as well as patient monitoring and care solutions. Its Pharmaceutical Diagnostics business supplies contrast agents and radiopharmaceuticals used in medical imaging.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.